Biotechnology

Preclinical screening strategy for T-cell therapies, developed by Sanderson and colleagues at the (Adaptimmune (ADAPY), provides a comprehensive framework to evaluate the safety and efficacy of T-cell therapies like CAR-T and SPEAR- T therapies, helping to minimize the unexpected toxicities before advancing engineered T cells into human trials.